THNR Holdings
Amplify Weight Loss Drug & Treatment ETF
1W: -4.4%
1M: -9.0%
3M: -7.5%
YTD: -3.4%
1Y: -0.2%
$24.56
-0.13 (-0.54%)
Weekly Expected Move ±2.8%
$23
$24
$25
$25
$26
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$5M
Holdings21
Top 10 Wt59.8%
Beta0.40
% Profitable55%
Coverage93%
Portfolio Valuation
P/E20.4
P/B5.0
P/S5.1
EV/EBITDA14.3
P/FCF24.0
PEG1.17
Profitability & Returns
Gross Margin71.1%
Net Margin24.9%
ROE25.9%
ROA15.4%
ROIC28.2%
Div Yield2.01%
Leverage & Liquidity
Debt/Equity0.28
Debt/Assets0.16
Net Debt/EBITDA-0.3x
Interest Cov28.1x
Current Ratio2.06
Quick Ratio1.57
Growth (YoY)
Revenue+16.2%
Net Income+7.9%
EPS+16.6%
FCF+38.5%
EBITDA+9.6%
Rev CAGR 3Y+34.4%
Quality Scores
Piotroski F6.0
Altman Z7.77
IS Quality73.7
IS Overall60.7
IS Value44.0
Median P/E21.8
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 20 | 96.1% | 24.8 |
| Financial Services | 1 | 3.0% | — |
| Other | 1 | 0.9% | — |
Smart Money Overlap
2 holdings with signals
Showing 22 of 22 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 10.07% | $582,011 | 503 | 38.2 | $1.1T | Healthcare |
| 2 | Novo Nordisk A/S | NVO | 8.42% | $486,575 | 12,835 | 9.5 | $165.7B | Healthcare |
| 3 | CSPC Pharmaceutical Group Ltd | 1093.HK | 5.82% | $336,233 | 262,000 | 13.0 | $113.3B | Healthcare |
| 4 | Amgen Inc | AMGN | 5.75% | $332,150 | 788 | 24.8 | $217.5B | Healthcare |
| 5 | Pfizer Inc | PFE | 5.38% | $310,754 | 10,896 | 36.7 | $158.4B | Healthcare |
| 6 | Innovent Biologics Inc | 1801.HK | 5.30% | $306,143 | 24,500 | 116.0 | $167.6B | Healthcare |
| 7 | AstraZeneca PLC | AZN | 5.27% | $304,855 | 1,888 | 23.4 | $243.3B | Healthcare |
| 8 | Regeneron Pharmaceuticals Inc | REGN | 4.64% | $268,428 | 354 | 17.6 | $75.7B | Healthcare |
| 9 | AbbVie Inc | ABBV | 4.56% | $263,421 | 1,007 | 74.0 | $464.3B | Healthcare |
| 10 | Roche Holding AG | ROP.SW | 4.56% | $263,409 | 630 | 22.5 | $275.2B | Healthcare |
| 11 | Gilead Sciences Inc | GILD | 4.55% | $262,775 | 1,763 | -55.7 | $179.5B | Healthcare |
| 12 | Merck & Co Inc | MRK | 4.55% | $262,866 | 1,809 | 114.5 | $356.4B | Healthcare |
| 13 | Viking Therapeutics Inc | VKTX | 4.55% | $263,278 | 8,076 | -6.4 | $3.5B | Healthcare |
| 14 | Chugai Pharmaceutical Co Ltd | 4519.T | 4.52% | $261,463 | 6,600 | 21.1 | $9.9T | Healthcare |
| 15 | Arrowhead Pharmaceuticals Inc | ARWR | 4.01% | $231,758 | 3,541 | -28.7 | $9.0B | Healthcare |
| 16 | Zealand Pharma A/S | ZEAL.CO | 3.95% | $228,283 | 5,542 | 6.8 | $18.2B | Healthcare |
| 17 | Hanmi Pharm Co Ltd | 128940.KS | 3.52% | $203,508 | 552 | 27.3 | $6.4T | Healthcare |
| 18 | Structure Therapeutics Inc | GPCR | 3.30% | $190,684 | 6,098 | -9.1 | $1.6B | Healthcare |
| 19 | Invesco Government & Agency Portfolio 12/31/2031 | AGPXX | 3.04% | $175,718 | 175,718 | — | $79.1B | Financial Services |
| 20 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276.HK | 2.37% | $136,908 | 21,400 | — | $329.6B | Healthcare |
| 21 | Kailera Therapeutics Inc | KLRA | 0.98% | $56,860 | 4,979 | — | $1.3B | Healthcare |
| 22 | Cash & Other Cash | — | 0.91% | $52,872 | 52,872 | — | — | — |